Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jainey P. James, Vinod Devaraji, Pradija Sasidharan & T. S. Pavan. (2023) Pharmacophore Modeling, 3D QSAR, Molecular Dynamics Studies and Virtual Screening on Pyrazolopyrimidines as anti-Breast Cancer Agents. Polycyclic Aromatic Compounds 43:8, pages 7456-7473.
Read now
Read now
Drew R Oostra & Erin R Macrae. (2014) Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer. Breast Cancer: Targets and Therapy 6, pages 103-113.
Read now
Read now
David M Roy & Logan A Walsh. (2014) Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors. Breast Cancer: Targets and Therapy 6, pages 81-91.
Read now
Read now
Articles from other publishers (2)
Yock Ping Chow, Lu Ping Tan, San Jiun Chai, Norazlin Abdul Aziz, Siew Woh Choo, Paul Vey Hong Lim, Rajadurai Pathmanathan, Noor Kaslina Mohd Kornain, Chee Lun Lum, Kin Choo Pua, Yoke Yeow Yap, Tee Yong Tan, Soo Hwang Teo, Alan Soo-Beng Khoo & Vyomesh Patel. (2017) Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma. Scientific Reports 7:1.
Crossref
Crossref
Ozlem Yersal. (2014) Biological subtypes of breast cancer: Prognostic and therapeutic implications. World Journal of Clinical Oncology 5:3, pages 412.
Crossref
Crossref